1. Noguchi M,Yi H,Rosenblatt HM,et al. Interleukin-2 receptorgamma chain mutation results in X-linked severe combinedimmunodeficiency in humans. Cell,1993,73: 147-157.
2. 噬血细胞综合征中国专家联盟,中华医学会儿科学分会血液学组. 噬血细胞综合征诊治中国专家共识. 中华医学杂志,2018,98: 91-95.
3. Ishii E. Hemophagocytic lymphohistiocytosis in children: pathogenesisand treatment. Front Pediatr,2016,4: 47.
4. Norouzi S, Aghamohammadi A, Mamishi S, et al. BacillusCalmette-Guérin ( BCG ) complications associated with primaryimmunodeficiency diseases. J Infect,2012,64: 543-554.
5. Dik Wai Luk A,Lee PP,Mao HW,et al. Family history of earlyinfant death correlates with earlier age at diagnosis but not shortertime to diagnosis for severe combined immunodeficiency. FrontImmunol,2017,8: 808.
6. 王静,王剑,罗丽娟,等. 噬血细胞综合征患儿临床预后及突变基因表型分析. 中国小儿急救医学,2019,26: 889-894.
7. Patiroglu T,HalukAkar H,van den Burg M,et al. X-linked severecombined immunodeficiency due to a novel mutation complicatedwith hemophagocytic lymphohistiocytosis and presented withinvagination: A case report. Eur J MicrobiolI mmunol ( Bp) ,2014,4: 174-176.
8. Ehl S,Astigarraga I,von Bahr Greenwood T,et al. Recommendationsfor the use of etoposide-based therapy and bone marrowtransplantation for the treatment of HLH: Consensus statements bythe HLH steering committee of the Histiocyte Society. J AllergyClinImmunol Pract,2018,6: 1508-1517.
9. 杨颖,李志刚,王天有. 儿童噬血细胞综合征与脓毒症免疫学发病机制的 研 究 进 展. 中国小儿血液与肿瘤杂志,2018,23:279-281.
( 收稿日期: 2020-07-29; 修回日期: 2020-09-15)
( 本文编辑: 刘英)